Valeant Pharmaceuticals Option Buyers Expect Another Earnings Win

VRX stock has moved higher after the drugmaker's last three earnings reports

Feb 27, 2018 at 2:35 PM
facebook X logo linkedin


Drugmaker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) will step up to the earnings plate before the open tomorrow. Despite a big earnings win for sector peer Mallinckrodt (MNK) today, the shares of VRX are down 0.5% to trade at $18.77 this afternoon. However, VRX stock has made huge moves after earnings, historically, and it looks like recent options buyers are betting on a rally soon.

Looking back eight quarters, Valeant Pharmaceuticals stock has moved an average of 20.4% the session after earnings, regardless of direction. The stock was in the black after the last three reports, though, jumping 17.1% the day following the company's November earnings release.

Recent options buyers have been betting on a fourth straight positive earnings reaction for VRX shares. On the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), traders have bought to open more than four Valeant Pharmaceuticals calls for every put in the past two weeks. The resulting 10-day call/put volume ratio of 4.17 is in the 85th percentile of its annual range, pointing to a much healthier-than-usual appetite for long VRX calls over puts of late.

Premium buyers can take comfort in the equity's Schaeffer's Volatility Scorecard (SVS), which stands at 99 out of 100. This further reflects that VRX stock has handily exceeded options traders' volatility expectations in the past year.

On the charts, the drug stock has been in a channel of higher lows and highs since its April nine-year low of $8.32. The shares peaked at $24.43 -- nearly triple that low -- in early January, before pulling back to test support at their 100-day moving average.

Should solid earnings once again propel Valeant stock to higher highs, there's still plenty of room on the bullish bandwagon. In fact, just three of 11 analysts consider VRX worthy of a "buy" or better endorsement, with Goldman Sachs recently initiating coverage with a "sell" rating.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI